Antimicrobial Susceptibility Testing Market to Surpass US$ 4.5 Billion by 2026 - Coherent Market Insights

Global Antimicrobial Susceptibility Testing Market, By Product Type (Manual Antimicrobial Susceptibility Testing Products {Susceptibility Testing Disks, Mic Strips, and Susceptibility Plates}, Automated Laboratory Instruments, and Consumables), By Application (Antibacterial, Antifungal, Anti-parasitic and Antiviral), By Method (Disk Diffusion, Rapid Automated AST, Broth Dilution, Gradient Diffusion, and Genotypic Methods), By End User (Hospitals, Pathology/Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 2.6 billion in 2017, and is projected to exhibit a CAGR of 6.2% over the forecast period (2018 - 2026), as highlighted in a new report published by .

Antimicrobial susceptibility testing (AST) and Antimicrobial resistance (AMR) are important criteria to be considered during the development of new antibiotics. AST aims to ensure that suitable antibiotics are prescribed to individuals by monitoring inhibition zone of antibiotics and emergence of resistant pathogens in infected individuals.

Antimicrobial susceptibility testing also helps to detect isolates with defined resistance mechanisms for infection prevention and control. Furthermore, AST is important in the assessment of resistance incidence and prevalence in epidemiological studies, which examine the origin and spread of resistance, including studies on the effectiveness of measures taken to counteract spread.

The government has been taking initiatives to address antimicrobial resistance. For instance, every November since 2015, WHO has been conducting the global, multi-year campaign with the theme ‘Antibiotics: Handle with care’, to spread awareness regarding multi-resistance.

Manufacturers in the antimicrobial susceptibility testing market are focused on developing rapid and cost effective tests for detection of different microbe resistance. For instance, in March 2016, Becton, Dickinson and Company launched the new BD Phoenix M50 ID/AST system, which helps to deliver the same rapid, accurate, and cost-effective testing as the legacy BD Phoenix 100, within a small footprint.

Furthermore, extensive research is being conducted by medical device manufacturers to offer cost-effective AST instruments. For instance, in 2017, the Society of Photo-Optical Instrumentation Engineers (SPIE) developed a cost-effective smartphone-based antimicrobial susceptibility test reader for drug resistance testing. It is a portable smartphone-based colorimetric 96-well microtiter plate (MTP) reader, which is capable of automated AST without the need for a trained diagnostician.

Browse 48 Market Data Tables and 25 Figures spread through 210 Pages and in-depth TOC on "Antimicrobial Susceptibility Testing Market, By Product Type (Manual Antimicrobial Susceptibility Testing Products {Susceptibility Testing Disks, Mic Strips, and Susceptibility Plates}, Automated Laboratory Instruments, and Consumables), By Application (Antibacterial, Antifungal, Anti-parasitic and Antiviral), By Method (Disk Diffusion, Rapid Automated AST, Broth Dilution, Gradient Diffusion and Genotypic Methods), By End User (Hospitals, Pathology/Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies and Contract Research Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

To know the latest trends and insights related to antimicrobial susceptibility testing market, click the link below:

https://www.coherentmarketinsights.com/market-insight/antimicrobial-susceptibility-testing-market-2449

Key Takeaways of the Antimicrobial Susceptibility Testing Market:

• The global antimicrobial susceptibility testing market is expected to expand at a CAGR of 6.2% during the forecast period (2018–2026), owing to increasing applications of AST and Antimicrobial Resistance (AMR) surveillance in the development of new antibiotics and emergence of multidrug resistance, globally.
• Among product type, the automated laboratory instruments segment is expected to grow at highest CAGR, as these instruments offer rapid, accurate, and efficient susceptibility testing, thereby enhancing workflow, reducing hands-on time, and enabling rapid reporting.
• Major players operating in the global antimicrobial susceptibility testing market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.